R&D Supercharging clinical development with RWE – with Recursion... Greater availability of real-world data and real-world evidence is rapidly changing the landscape of drug development.
Digital “Data is our currency” – with Ginkgo Datapoints’ John Andros... Successful use of AI is becoming a key differentiator for pharma companies.
R&D Sponsored Webinar recap: The future of cell and gene therapy in rare d... For decades, treatment options for rare diseases have been limited, often focusing on symptom management rather than addressing the root cause of them
Sales & Marketing Executing established pharma brand strategy: Key considerati... As blockbuster drug patents edge closer to expiry, pharma companies must rethink how they invest in, support, and scale established brands
Sales & Marketing Partner Content The ESG in Life Sciences Summit is coming to the West Coast! The ESG in Life Sciences Summit West is coming to San Francisco! (July 8-10, 2025).
R&D Partner Content World’s Largest Biopharma Forum for all mRNA Stakeholders The mRNA field is on the cusp of revolutionary change, with cancer vaccines, in vivo cell engineering and gene editing technologies unleashing the next advancements of therapeutic candidat
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
